Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
作者信息
Kinoshita Shigeru, Ueta Mayumi
机构信息
Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
出版信息
Front Med (Lausanne). 2021 Dec 22;8:811570. doi: 10.3389/fmed.2021.811570. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Front Med (Lausanne). 2021 Dec 22;8:811570. doi: 10.3389/fmed.2021.811570. eCollection 2021.
2
Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Expert Rev Clin Immunol. 2020 Mar;16(3):285-291. doi: 10.1080/1744666X.2020.1729128. Epub 2020 Feb 28.
3
Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.
Front Med (Lausanne). 2021 Nov 17;8:651247. doi: 10.3389/fmed.2021.651247. eCollection 2021.
4
Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.
Front Med (Lausanne). 2021 Dec 1;8:649661. doi: 10.3389/fmed.2021.649661. eCollection 2021.
5
Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand.
Br J Ophthalmol. 2018 Sep;102(9):1303-1307. doi: 10.1136/bjophthalmol-2017-311823. Epub 2018 Apr 29.
6
Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population.
Sci Rep. 2021 Feb 3;11(1):2928. doi: 10.1038/s41598-021-82400-3.
7
Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.
JAMA Ophthalmol. 2017 Apr 1;135(4):355-360. doi: 10.1001/jamaophthalmol.2017.0074.
8
Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies.
Expert Rev Clin Immunol. 2020 Apr;16(4):373-387. doi: 10.1080/1744666X.2020.1740591. Epub 2020 Apr 2.
9
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.
10
Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES183-DES191. doi: 10.1167/iovs.17-23537.
引用本文的文献
1
Understanding the Gap Between Acute Complications and Long-Term Sequelae in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Bandung, West Java, Indonesia: Experience from Two Institutions.
Clin Cosmet Investig Dermatol. 2025 Apr 21;18:979-988. doi: 10.2147/CCID.S514590. eCollection 2025.
本文引用的文献
1
Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease.
Ocul Surf. 2016 Apr;14(2):168-88. doi: 10.1016/j.jtos.2016.02.001. Epub 2016 Feb 13.
2
Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Am J Ophthalmol. 2015 Aug;160(2):228-237.e2. doi: 10.1016/j.ajo.2015.05.002. Epub 2015 May 13.
3
Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
Am J Ophthalmol. 2014 Nov;158(5):983-93. doi: 10.1016/j.ajo.2014.07.012. Epub 2014 Jul 15.
4
Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.
Sci Rep. 2014 Apr 30;4:4862. doi: 10.1038/srep04862.
5
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
Pharmacogenomics J. 2013 Feb;13(1):60-9. doi: 10.1038/tpj.2011.41. Epub 2011 Sep 13.
6
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
N Engl J Med. 2011 Mar 24;364(12):1134-43. doi: 10.1056/NEJMoa1013297.
7
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
Hum Mol Genet. 2011 Mar 1;20(5):1034-41. doi: 10.1093/hmg/ddq537. Epub 2010 Dec 10.
8
Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Ophthalmology. 2009 Apr;116(4):685-90. doi: 10.1016/j.ophtha.2008.12.048. Epub 2009 Feb 25.
9
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
Pharmacogenet Genomics. 2008 Feb;18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c.
10
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.
J Invest Dermatol. 2008 Jan;128(1):35-44. doi: 10.1038/sj.jid.5701033. Epub 2007 Sep 6.
Zotero 插件